Respiratory Care Devices Market Expected to Reach US$40.59 billion by 2033 as Rising Respiratory Diseases and Home Healthcare Adoption Drive Demand

Market Size and Growth

The global demand for respiratory care devices is growing rapidly as respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and lung infections continue to increase worldwide. Respiratory care devices play a critical role in diagnosing, monitoring, and treating respiratory disorders in hospitals, clinics, and home healthcare settings. The Global Respiratory Care Devices Market reached US$22.85 billion in 2023 and is expected to reach US$40.59 billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033, according to DataM Intelligence report.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/respiratory-care-devices-market?sb

Key Development:

United States: Recent Industry Developments

✅ In February 2026, Beyond Air highlighted new clinical research showing the therapeutic potential of high-dose inhaled nitric oxide (iNO) as an antimicrobial respiratory therapy for pneumonia, bronchiolitis, and other severe lung infections. The development supports innovation in advanced respiratory treatment technologies and next-generation respiratory care devices.

✅ In January 2026, several U.S. respiratory technology startups expanded development of portable and AI-enabled ventilation systems, focusing on compact respiratory support devices designed for home healthcare and emergency respiratory treatment. These innovations aim to improve accessibility, remote monitoring, and patient mobility in respiratory care.

✅ In December 2025, leading respiratory device manufacturers increased investments in digital inhaler technologies with integrated dose-tracking sensors, enabling remote monitoring and improved adherence for asthma and COPD therapies. The initiative strengthens connected respiratory care ecosystems and supports digital disease management.

✅ In December 2025, U.S. medical device companies expanded development of next-generation portable ventilators and oxygen therapy systems to improve emergency respiratory support and hospital-to-home care transitions. The advancements focus on lightweight design, improved airway monitoring, and enhanced patient comfort.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=respiratory-care-devices-market

Japan: Recent Industry Developments

✅ In February 2026, Japanese healthcare providers increased deployment of digital respiratory care platforms integrated with portable oxygen therapy and monitoring devices, enabling remote respiratory monitoring and telehealth-supported lung disease management across hospitals and home-care settings.

✅ In January 2026, medical device developers in Japan expanded research on portable ventilation and respiratory therapy technologies, focusing on compact respiratory support systems designed for aging populations and long-term home healthcare applications.

✅ In December 2025, Japanese healthcare technology companies intensified collaboration with global respiratory device manufacturers to advance smart inhaler systems and connected respiratory monitoring solutions, improving disease management for patients with chronic respiratory conditions.

✅ In December 2025, healthcare institutions in Japan increased adoption of advanced oxygen delivery and respiratory therapy equipment to support treatment of COPD, pneumonia, and other respiratory disorders while enhancing clinical respiratory care infrastructure.

Rising Burden of Respiratory Diseases Driving Market Growth

One of the primary factors driving the respiratory care devices market is the increasing prevalence of respiratory diseases across the globe. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea are becoming more common due to environmental pollution, tobacco consumption, occupational hazards, and aging populations.

According to global health organizations, respiratory diseases are among the leading causes of morbidity and mortality worldwide. COPD alone affects hundreds of millions of individuals globally and is one of the leading causes of death. This growing disease burden has significantly increased the demand for respiratory diagnostic and therapeutic devices.

Healthcare systems are investing heavily in respiratory care infrastructure to improve treatment accessibility and disease management. Hospitals are expanding intensive care units with advanced ventilators and respiratory monitoring systems, while home healthcare providers are adopting portable oxygen concentrators and CPAP devices to support long-term patient care.

North America, Europe, and Asia-Pacific represent major markets due to high disease prevalence, strong healthcare infrastructure, and increasing healthcare expenditure.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/respiratory-care-devices-market?sb

Competitive Landscape and Industry Leadership

The global respiratory care devices market is highly competitive, with several major medical technology companies developing advanced respiratory solutions for hospitals, clinics, and home healthcare providers. Leading companies operating in the market include:

=> Koninklijke Philips N.V.; Fitbit (Google); Garmin Ltd.; Medtronic; Omron; Withings; VitalConnect; Polar Electro; Sotera, Inc.; INVIZA Corporation; Dexcom, Inc.; GE HealthCare; CONTEC MEDICAL SYSTEMS CO., LTD; Nanowear Inc. among others.

Emerging Players

=> The emerging players in the respiratory care devices market include Vivos Therapeutics, Omron Healthcare, AirSep Corporation and among others.

Key Segments:

By Product Type

Therapeutic Devices dominate the market with 40% share, driven by the increasing use of ventilators, oxygen concentrators, and CPAP/BiPAP systems for managing chronic respiratory conditions. Monitoring Devices account for 25%, supported by the rising adoption of pulse oximeters, capnography systems, and respiratory monitoring technologies for continuous patient observation. Diagnostic Devices hold 20% share, owing to the growing demand for spirometers, imaging systems, and pulmonary function testing equipment. Consumables and Accessories represent 15%, including masks, tubing, filters, and nasal cannulas, which are essential for respiratory therapy procedures.

By Application

Chronic Obstructive Pulmonary Disease (COPD) leads with 35% share, as the condition remains one of the most prevalent respiratory diseases globally, requiring long-term respiratory support and monitoring. Asthma accounts for 22%, fueled by the rising prevalence among children and adults due to pollution and lifestyle changes. Obstructive Sleep Apnea (OSA) holds 18% share, driven by the growing use of CPAP and BiPAP devices for sleep disorder management. Respiratory Distress Syndrome represents 15%, particularly in neonatal and critical care settings. Others contribute 10%, including respiratory infections and pulmonary complications.

By End User

Hospitals and Clinics dominate the segment with 60% share, due to advanced respiratory care infrastructure, intensive care units (ICUs), and the availability of specialized healthcare professionals. Home Care Settings account for 28%, driven by the increasing preference for home-based respiratory therapy and portable medical devices. Ambulatory Surgical Centers (ASCs) hold 12% share, supported by the rising number of outpatient respiratory procedures and diagnostic tests.

By Region

North America leads the market with 34% share, supported by advanced healthcare infrastructure, high adoption of respiratory devices, and increasing prevalence of chronic respiratory diseases. Europe follows with 27%, driven by strong healthcare systems and rising geriatric population prone to respiratory disorders. Asia-Pacific accounts for 24%, fueled by growing healthcare investments, increasing pollution levels, and expanding patient population. South America represents 8%, while Middle East & Africa hold 7%, supported by improving healthcare facilities and growing awareness of respiratory health.

Outlook & Opportunity Analysis (2025-2033)

The respiratory care devices market is expected to experience steady growth through 2033, driven by the increasing prevalence of respiratory diseases, aging population, and rising demand for home healthcare solutions. Technological advancements such as portable ventilators, smart respiratory monitoring systems, and AI-integrated diagnostic tools are expected to further accelerate market expansion. Additionally, emerging economies in Asia-Pacific and the Middle East present significant growth opportunities due to improving healthcare infrastructure and rising healthcare spending.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.